Category | Insight journal – Dealtalk

Mylan bids on old drugs of GSK

Posted on 22 August 2014

Several companies, including Mylan , have submitted a second round of bidding for a portfolio of older GlaxoSmithKline drugs.  

Tags: , , , , ,

Cubist Pharma, the next acquisition target for big pharmaceuticals

Posted on 19 August 2014

The timing may be right for a takeover of Cubist Pharmaceuticals.

Tags: , ,

Roche to buy 40% stake in Chugai Pharma

Posted on 18 August 2014

Roche Holding is in talks to buy the almost 40 percent of Chugai Pharmaceutical that it doesn’t already own to gain full control of its Japanese partner for oncology and arthritis drugs, according to people familiar with the matter.

Tags: ,

InterMune looking for oppurtunities for buyout

Posted on 15 August 2014

Multiple sources are reporting that biotechnology company, InterMune, Inc. (ITMN), is officially preparing for a buyout.

Tags: ,

Life Science M&A Deal Trends in Q2, 2014

Posted on 14 August 2014

By Steve Poile                                     With 110 deals announced, the second quarter continued on from the strong start for life science M&A during 2014.

Tags: ,

Reckitt Benckiser spins off its pharmaceutical division

Posted on 29 July 2014

Reckitt Benckiser, the consumer goods giant that makes Nurofen and Dettol, plans to spin off its US-based pharmaceutical business.

Tags: , ,

Biotech rumour mill has it that Siemens plans for a spin off

Posted on 15 July 2014

Rumour mill has it that Siemens is reportedly investigating a spinout of its Siemens Healthcare division’s IT unit, which could be worth more than $1 billion.

Tags: ,

Abbvie chases Shire again

Posted on 01 July 2014

The boss of US drug-maker AbbVie is flying into London this week to court Shire’s shareholders and try to convince them of the merits of a potential takeover.

Tags: , , ,

Shire rejects AbbVie’s acquistion offer

Posted on 23 June 2014

Shire rejects Abbvie‘s $46 billion bid for acquistion.

Tags: , , , ,

Medtronic in the talks to acquire Covidien

Posted on 16 June 2014

Medtronic Inc is in advanced talks to acquire rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.

Tags: , ,

RSS Feed Linked In Twitter

Latest Tweets